Text Size

Resident Surveillance of Pediatric Patient Developmental Status at the Two Month Preventive Care Visit

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sarah Nyp, Children's Mercy Hospital Kansas City
ClinicalTrials.gov Identifier:
NCT00465361
First received: April 23, 2007
Last updated: February 6, 2012
Last verified: December 2011
History of Changes
Results First Received: February 8, 2011  
Study Type: Interventional
Study Design: Allocation: Non-Randomized;   Endpoint Classification: Efficacy Study;   Intervention Model: Single Group Assignment;   Masking: Open Label
Conditions: Growth & Development
Child Development
Internship and Residency
Education, Medical
Developmental Disabilities
Intervention: Procedure: performance feedback with an educational module

  Participant Flow
  Show Participant Flow


  Baseline Characteristics
  Hide Baseline Characteristics

Reporting Groups
  Description
Intervention Performance after receiving feedback and educational module

Baseline Measures
    Intervention  
Number of Participants  
[units: participants]
 		  7  
Age  
[units: participants]
 		 
<=18 years     0  
Between 18 and 65 years     7  
>=65 years     0  
Age  
[units: years]
Mean ± Standard Deviation 		  28  ± 2  
Gender  
[units: participants]
 		 
Female     5  
Male     2  
Region of Enrollment  
[units: participants]
 		 
United States     7  



  Outcome Measures

1.  Primary:   Presence of Resident Surveillance Behaviors of Specific Aspects of Developmental Status at the Two Month Preventive Care Visit   [ Time Frame: Residents were observed during each of the eligible preventive care visits. Each visit was an average of 20 minutes in length. Preventive care visits were observed over a 13 month time period. ]
  Show Outcome Measure 1


  Serious Adverse Events
  Show Serious Adverse Events


  Other Adverse Events
  Show Other Adverse Events


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Limitations and Caveats
Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
Long-term effects of intervention are unknown.  


Results Point of Contact:  
Name/Title: Sarah S. Nyp
Organization: Children's Mercy Hospitals and Clinics
phone: 816-234-3000
e-mail: ssnyp@cmh.edu


No publications provided


Responsible Party: Sarah Nyp, Children's Mercy Hospital Kansas City
ClinicalTrials.gov Identifier: NCT00465361     History of Changes
Other Study ID Numbers: 07 02-027E
Study First Received: April 23, 2007
Results First Received: February 8, 2011
Last Updated: February 6, 2012
Health Authority: United States: Institutional Review Board